American Factory Tracker
About
PharmaceuticalsLebanon, IndianaAnnounced May 24, 2022

Eli Lilly

See all projects by Eli Lilly →

Lilly's LEAP Research and Innovation District campus in Boone County, Indiana — a multi-facility API and advanced-therapies manufacturing site. Initial commitment $3.7B / 700 jobs announced May 2022; expanded May 2024 with an additional $5.3B / 200 jobs to a cumulative $9B / 900-job site-level total. The Advanced Therapies plant opened May 6, 2026; API manufacturing and the Medicine Foundry remain under construction with target openings in 2027. Cumulative campus-level figures per Lilly's May 2024 announcement; not double-counted at other Lilly sites.

Investment
$9.00B
Permanent jobs announced
900
Status
Under Construction
Expected opening
Jan 1, 2027
Why it matters

The pharmaceuticals context.

Pharmaceutical manufacturers are committing billions to new U.S. production capacity for active ingredients, injectable medicines, biologics and other high-demand treatments. North Carolina and Indiana remain major centers of investment, while new facilities are being planned across the South. The current project pipeline includes both large greenfield campuses and major expansions of established production sites.

Project record

At a glance

Company
Eli Lilly
Industry
Pharmaceuticals
Location
Lebanon, Indiana
Investment
$9.00B
Permanent jobs announced
900
Status
Under Construction
Announced
May 24, 2022
Expected opening
Jan 1, 2027
Added to tracker
Apr 15, 2025
Sources

Official references

  • Primary source
    https://iedc.in.gov/events/news/details/2024/05/24/gov.-holcomb-joins-lilly-to-announce-additional-5.3-billion-investment-at-leap-district
Related

Other projects to know

In Indiana
Across Pharmaceuticals
Back to the tracker/projects/eli-lilly-lebanon